Jennifer M Rosenbluth1, Beth A Overmoyer2. 1. Susan F. Smith Center for Women's Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. 2. Susan F. Smith Center for Women's Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Beth_overmoyer@dfci.harvard.edu.
Abstract
PURPOSE OF REVIEW: Inflammatory breast cancer (IBC) is an uncommon but highly aggressive subtype of breast cancer that contributes significantly to breast cancer-related mortality. In this review, we provide an overview of the clinical and molecular characteristics of IBC, and highlight some areas of need for ongoing research. RECENT FINDINGS: The disease is characterized by florid tumor emboli that obstruct dermal lymphatics, leading to swelling and inflammation of the affected breast. Recent studies have focused on tumor cell intrinsic features, such as signaling through pathways involved in growth and stem-like behavior, as well as extrinsic features, such as the immune system, that can be leveraged to develop new potential therapies. Key efforts have led to an increase in awareness of the disease as well as new insights into IBC pathogenesis. However, there is a strong need for new therapies designed specifically for IBC, and many unanswered questions remain.
PURPOSE OF REVIEW: Inflammatory breast cancer (IBC) is an uncommon but highly aggressive subtype of breast cancer that contributes significantly to breast cancer-related mortality. In this review, we provide an overview of the clinical and molecular characteristics of IBC, and highlight some areas of need for ongoing research. RECENT FINDINGS: The disease is characterized by florid tumor emboli that obstruct dermal lymphatics, leading to swelling and inflammation of the affected breast. Recent studies have focused on tumor cell intrinsic features, such as signaling through pathways involved in growth and stem-like behavior, as well as extrinsic features, such as the immune system, that can be leveraged to develop new potential therapies. Key efforts have led to an increase in awareness of the disease as well as new insights into IBC pathogenesis. However, there is a strong need for new therapies designed specifically for IBC, and many unanswered questions remain.
Entities:
Keywords:
Clinical trials; Dermal lymphatic invasion; Inflammatory breast cancer; Locally advanced breast cancer; Tumor emboli
Authors: Sabin B Motwani; Eric A Strom; Naomi R Schechter; Charles E Butler; Gordon K Lee; Howard N Langstein; Steven J Kronowitz; Funda Meric-Bernstam; Nuhad K Ibrahim; Thomas A Buchholz Journal: Int J Radiat Oncol Biol Phys Date: 2006-06-09 Impact factor: 7.038
Authors: Kenneth W Hance; William F Anderson; Susan S Devesa; Heather A Young; Paul H Levine Journal: J Natl Cancer Inst Date: 2005-07-06 Impact factor: 13.506
Authors: Kenneth L van Golen; LiWei Bao; Melinda M DiVito; ZhiFen Wu; George C Prendergast; Sofia D Merajver Journal: Mol Cancer Ther Date: 2002-06 Impact factor: 6.261
Authors: Vered Stearns; C Alexander Ewing; Rebecca Slack; Marie F Penannen; Daniel F Hayes; Theodore N Tsangaris Journal: Ann Surg Oncol Date: 2002-04 Impact factor: 5.344
Authors: Melinda M Mortenson; Philip D Schneider; Vijay P Khatri; Thomas R Stevenson; Thomas P Whetzel; Eiler J Sommerhaug; James E Goodnight; Richard J Bold Journal: Arch Surg Date: 2004-09
Authors: Kenneth L van Golen; Li Wei Bao; Quintin Pan; Fred R Miller; Zhi Fen Wu; Sofia D Merajver Journal: Clin Exp Metastasis Date: 2002 Impact factor: 5.150
Authors: Dongwei Zhang; Tiffany A LaFortune; Savitri Krishnamurthy; Francisco J Esteva; Massimo Cristofanilli; Ping Liu; Anthony Lucci; Balraj Singh; Mien-Chie Hung; Gabriel N Hortobagyi; Naoto T Ueno Journal: Clin Cancer Res Date: 2009-10-13 Impact factor: 12.531
Authors: Ian J Bristol; Wendy A Woodward; Eric A Strom; Massimo Cristofanilli; Delora Domain; S Eva Singletary; George H Perkins; Julia L Oh; Tse-Kuan Yu; Welela Terrefe; Aysegul A Sahin; Kelly K Hunt; Gabriel N Hortobagyi; Thomas A Buchholz Journal: Int J Radiat Oncol Biol Phys Date: 2008-04-24 Impact factor: 7.038
Authors: Theresa Relation; Yaming Li; James L Fisher; Allan Tsung; Bridget Oppong; Mariam F Eskander; Samilia Obeng-Gyasi Journal: Surgery Date: 2021-11-30 Impact factor: 3.982
Authors: R Jagsi; G Mason; B A Overmoyer; W A Woodward; S Badve; R J Schneider; J E Lang; M Alpaugh; K P Williams; D Vaught; A Smith; K Smith; K D Miller Journal: Breast Cancer Res Treat Date: 2022-01-01 Impact factor: 4.872
Authors: Valeria Villarreal-García; José Roberto Estupiñan-Jiménez; Pablo E Vivas-Mejía; Vianey Gonzalez-Villasana; José Manuel Vázquez-Guillén; Diana Reséndez-Pérez Journal: Front Oncol Date: 2022-09-26 Impact factor: 5.738